InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+57.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Vieser Jaime, Director. Officer active across 3 companies, notably Ziopharm Oncology INC. Cumulatively, 9 reports have been recorded. Split: 4 buys · 1 sell. Total volume traded: €1.1m. Activity tracked since 4 March 2021. The latest transaction was filed on 13 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
17,465 shares0Common StockSEC:0000950170-25-054429:0
2,182 shares@ US$2.010.5% of flowCommon StockSEC:0000950170-25-001257:0
25,000 sharesClass A Ordinary Share, par value $0.0001 per shareSEC:0001213900-24-109470:0
Ideal exit: 12 Sept 2025 (T+270)
1,250,000 shares@ US$0.6599.5% of flowCommon StockSEC:0000899243-22-037274:0
Ideal exit: 26 Aug 2023 (T+270)
40,000 shares0Common StockSEC:0000899243-22-023985:0
100,000 shares@ US$1.9150.0% of flowCommon StockSEC:0001209191-21-059131:0
Ideal exit: 26 Jun 2022 (T+270)
100,000 shares@ US$1.91100.0% of flowCommon StockSEC:0001209191-21-059131
Ideal exit: 26 Jun 2022 (T+270)
4,167 sharesCommon StockSEC:0001209191-21-030745
4,167 shares0Common StockSEC:0001209191-21-030745:0
9 of 9 declarations
About Vieser Jaime
Jaime Vieser is a director at ZIOPHARM ONCOLOGY INC and Alaunos Therapeutics, Inc. In this role, he is involved in the strategic and operational management of the companies. With expertise in the pharmaceutical sector, he contributes to innovation and service improvement.
